Stereotactic Radiotherapy for Localised Prostate Cancer: Time to Clarify the Possible Impact of Concurrent Androgen Deprivation Therapy

Arch Esp Urol. 2024 Apr;77(3):315-317. doi: 10.56434/j.arch.esp.urol.20247703.41.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Androgen Antagonists* / therapeutic use
  • Combined Modality Therapy
  • Humans
  • Male
  • Prostatic Neoplasms* / radiotherapy
  • Radiosurgery*

Substances

  • Androgen Antagonists